Cargando…
Cytomegalovirus Enterocolitis secondary to experimental COVID-19 therapy
The novel coronavirus-2019 (COVID-19) has caused a global pandemic of historical proportions, infecting millions of people worldwide. Due to its high mortality rate and a paucity of clinical data, experimental therapies have been utilized with uncertain success and, unfortunately, poor outcomes. We...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507983/ https://www.ncbi.nlm.nih.gov/pubmed/32983888 http://dx.doi.org/10.1016/j.idcr.2020.e00962 |